New Research Verifies TASINs as Viable Target for Colon Cancer Therapies
Thursday, October 20, 2016 - 12:31
in Biology & Nature
A small molecule called TASIN-1 can selectively kill cells with a mutation that is considered to be a precursor to colon cancer, while sparing related normal cells, UT Southwestern Medical Center cancer biologists have demonstrated.